Clinical Trials Directory

Trials / Unknown

UnknownNCT05468528

Clinical Value of Linear Ablation Without Pulmonary Vein Isolation in Persistent Atrial Fibrillation

Clinical Value of Linear Ablation Without Pulmonary Vein Isolation in Persistent Atrial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
207 (estimated)
Sponsor
China National Center for Cardiovascular Diseases · Other Government
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Based on previous theoretical foundation and clinical practice experience, the investigators further propose a multi-center randomized prospective trial to compare the pure linear ablation strategy without pulmonary vein isolation to traditional PVI ablation for persistent AF. population size is 207. The participants will be randomized to the linear ablation group and PVI ablation group with a 2:1 ratio. the follow-up period is 12 months. The primary outcome is freedom from atrial fibrillation, the secondary outcome is complications related to ablation.

Detailed description

Pulmonary vein isolation is recommended as the cornerstone of catheter ablation of atrial fibrillation by current guidelines, However, meta-analysis suggests that the success rate of continuous pulmonary vein isolation for persistent atrial fibrillation is only 43%. Therefore, in addition to pulmonary vein isolation, further research on substrate modification in the treatment of atrial fibrillation is particularly important. Based on our previous theoretical foundation and clinical practice experience, the investigators further propose a multi-center randomized prospective trial to compare the pure linear ablation strategy without pulmonary vein isolation to traditional PVI ablation for persistent AF. The linear ablation is performed on the basis of Ω-type linear ablation. Further stepwise ablation of the left atrial anterior wall increases the blockage of the LA roof and the MVA isthmus. Ablation in CS or ethanol ablation of vein of Marshall. Also, epicardial ablation on the roof or rigid between LAA-LPVs may be applied if necessary.

Conditions

Interventions

TypeNameDescription
PROCEDUREcatheter radiofrequency ablation(individualized stepwise linear without pulmonary vein isolation)individualized stepwise linear ablation without pulmonary vein isolation
PROCEDUREcatheter radiofrequency ablation(PVI)pulmonary vein isolation

Timeline

Start date
2022-08-01
Primary completion
2024-05-01
Completion
2024-07-01
First posted
2022-07-21
Last updated
2022-07-21

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05468528. Inclusion in this directory is not an endorsement.